Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Explorative PK Study Comparing 600 mg Rifampicin i.v. With 750 mg and 900 mg Rifampicin Oral in Tuberculous Meningitis Patients

NCT01802502 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT01802502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01802502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Explorative PK Study Comparing 600 mg Rifampicin i.v. With 750 mg and 900 mg Rifampicin Oral in Tuberculous Meningitis Patients
Lead sponsor
Universitas Padjadjaran
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2013
Completion date
April 30, 2014
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculous meningitis